BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34630502)

  • 1. hnRNPA2B1 Promotes Colon Cancer Progression via the MAPK Pathway.
    Tang J; Chen Z; Wang Q; Hao W; Gao WQ; Xu H
    Front Genet; 2021; 12():666451. PubMed ID: 34630502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner.
    Hao W; Chen Z; Tang J; Yang R; Gao WQ; Xu H
    J Transl Med; 2023 Nov; 21(1):861. PubMed ID: 38017546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA.
    Jiang F; Tang X; Tang C; Hua Z; Ke M; Wang C; Zhao J; Gao S; Jurczyszyn A; Janz S; Beksac M; Zhan F; Gu C; Yang Y
    J Hematol Oncol; 2021 Apr; 14(1):54. PubMed ID: 33794982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the HNRNPA2B1/
    Sun M; Shen Y; Jia G; Deng Z; Shi F; Jing Y; Xia S
    J Cancer; 2023; 14(7):1242-1256. PubMed ID: 37215455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
    Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
    Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HNRNPA2B1, as a m
    Zhu F; Yang T; Yao M; Shen T; Fang C
    Front Oncol; 2021; 11():716921. PubMed ID: 34631545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of M6A Reader HNRNPA2B1 Associated with Poor Prognosis and Tumor Progression in Lung Adenocarcinoma.
    Wang W; Li S
    Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37877146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m
    Guo H; Wang B; Xu K; Nie L; Fu Y; Wang Z; Wang Q; Wang S; Zou X
    Front Oncol; 2020; 10():553045. PubMed ID: 33134163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hnRNPA2B1 regulates the alternative splicing of BIRC5 to promote gastric cancer progression.
    Peng WZ; Zhao J; Liu X; Li CF; Si S; Ma R
    Cancer Cell Int; 2021 May; 21(1):281. PubMed ID: 34044823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer.
    Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B
    J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal protein RPL5 regulates colon cancer cell proliferation and migration through MAPK/ERK signaling pathway.
    Zhang H; Liu J; Dang Q; Wang X; Chen J; Lin X; Yang N; Du J; Shi H; Liu Y; Han J
    BMC Mol Cell Biol; 2022 Nov; 23(1):48. PubMed ID: 36384455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma.
    Jia C; Guo Y; Chen Y; Wang X; Xu Q; Zhang Y; Quan L
    J Transl Med; 2022 Nov; 20(1):537. PubMed ID: 36401285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster.
    Li K; Chen J; Lou X; Li Y; Qian B; Xu D; Wu Y; Ma S; Zhang D; Cui W
    Front Cell Dev Biol; 2021; 9():658642. PubMed ID: 34277606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
    Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
    Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNRNPA2B1-Mediated MicroRNA-92a Upregulation and Section Acts as a Promising Noninvasive Diagnostic Biomarker in Colorectal Cancer.
    Li Y; Li K; Lou X; Wu Y; Seery S; Xu D; Pei Y; Qian B; Wu Y; Liang S; Wu K; Cui W
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK signaling pathway.
    Meng LD; Shi GD; Ge WL; Huang XM; Chen Q; Yuan H; Wu PF; Lu YC; Shen P; Zhang YH; Cao SJ; Miao Y; Tu M; Jiang KR
    Cancer Lett; 2020 Dec; 494():107-120. PubMed ID: 32814086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
    Xu J; Chen Q; Tian K; Liang R; Chen T; Gong A; Mathy NW; Yu T; Chen X
    Oncol Rep; 2020 Sep; 44(3):973-986. PubMed ID: 32705223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNRNPA2B1 regulates the epithelial-mesenchymal transition in pancreatic cancer cells through the ERK/snail signalling pathway.
    Dai S; Zhang J; Huang S; Lou B; Fang B; Ye T; Huang X; Chen B; Zhou M
    Cancer Cell Int; 2017; 17():12. PubMed ID: 28077929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter Pylori-Enhanced hnRNPA2B1 Coordinates with PABPC1 to Promote Non-m
    Yu Y; Yang YL; Chen XY; Chen ZY; Zhu JS; Zhang J
    Adv Sci (Weinh); 2024 Jun; ():e2309712. PubMed ID: 38887155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.